Trial · NCT04712669
Adverse events1,168
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,168
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | COVID-19 | Infections and infestations | Rodatristat Ethyl 300 mg BID | 5 | 36 | 5 |
| other | COVID-19 | Infections and infestations | Rodatristat Ethyl 600 mg BID | 3 | 36 | 3 |
| other | COVID-19 | Infections and infestations | Placebo | 8 | 36 | 8 |
| other | COVID-19 | Infections and infestations | Placebo-Rodatristat Ethyl 300 mg | 3 | 15 | 5 |
| other | COVID-19 | Infections and infestations | Placebo-Rodatristat Ethyl 600 mg | 7 | 16 | 8 |
| other | COVID-19 | Infections and infestations | Rodatristat Ethyl 300 Mg-Rodatristat Ethyl 300 mg | 5 | 22 | 5 |
| other | COVID-19 | Infections and infestations | Rodatristat Ethyl 300 Mg-Rodatristat Ethyl 600 mg | 1 | 2 | 1 |
| other | COVID-19 | Infections and infestations | Rodatristat Ethyl 600 Mg-Rodatristat Ethyl 600 mg | 6 | 21 | 6 |
| other | Nasopharyngitis | Infections and infestations | Rodatristat Ethyl 300 mg BID | 1 | 36 | 1 |
| other | Nasopharyngitis | Infections and infestations | Rodatristat Ethyl 600 mg BID | 2 | 36 | 2 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 3 | 36 | 4 |
| other | Nasopharyngitis | Infections and infestations | Placebo-Rodatristat Ethyl 300 mg | 0 | 15 | 0 |
| other | Nasopharyngitis | Infections and infestations | Placebo-Rodatristat Ethyl 600 mg | 0 | 16 | 0 |
| other | Nasopharyngitis | Infections and infestations | Rodatristat Ethyl 300 Mg-Rodatristat Ethyl 300 mg | 0 | 22 | 0 |
| other | Nasopharyngitis | Infections and infestations | Rodatristat Ethyl 300 Mg-Rodatristat Ethyl 600 mg | 0 | 2 | 0 |
| other | Nasopharyngitis | Infections and infestations | Rodatristat Ethyl 600 Mg-Rodatristat Ethyl 600 mg | 0 | 21 | 0 |
| other | Respiratory tract infection | Infections and infestations | Rodatristat Ethyl 300 mg BID | 1 | 36 | 1 |
| other | Respiratory tract infection | Infections and infestations | Rodatristat Ethyl 600 mg BID | 1 | 36 | 1 |
| other | Respiratory tract infection | Infections and infestations | Placebo | 2 | 36 | 2 |
| other | Respiratory tract infection | Infections and infestations | Placebo-Rodatristat Ethyl 300 mg | 2 | 15 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04712669/events